Institutional members access full text with Ovid®

Share this article on:

Soft-Tissue Filler Complications: The Important Role of Biofilms

Rohrich, Rod J. M.D.; Monheit, Gary M.D.; Nguyen, Alexander T. M.D.; Brown, Spencer A. Ph.D.; Fagien, Steven M.D.

Plastic and Reconstructive Surgery: April 2010 - Volume 125 - Issue 4 - p 1250-1256
doi: 10.1097/PRS.0b013e3181cb4620
Cosmetic: Special Topics

Dallas, Texas; Birmingham, Ala.; and Boca Raton, Fla.

From the Department of Plastic Surgery, University of Texas Southwestern Medical Center; the Departments of Dermatology and Ophthalmology, University of Alabama at Birmingham; and Aesthetic Oculoplastic Surgery (private practice).

Received for publication May 1, 2009; accepted September 14, 2009.

Disclosures: Gary Monheit, M.D., is a consultant for Allergan, Dermik, Genzyme, Colbar LifeScience, Contura, Ipsen/Medicis, Stiefel, Melafind, Revance, Kythera, Galderma, and Mentor. None of the other authors has a financial interest regarding the contents of this article.

Rod J. Rohrich, M.D.; Department of Plastic Surgery; University of Texas Southwestern Medical Center; 1801 Inwood Road; Dallas, Texas 75390-9132; rod.rohrich@utsouthwestern.edu

Correction: Soft-Tissue Filler Complications: The Important Role of Biofilms

In Figure 2, there is a misspelling in the figure. In the first box in the algorithm, the word “Fluctance” should be “Fluctuance.”

This correction is published in the June 2010 issue of the Journal.

©2010American Society of Plastic Surgeons